Should I Buy DVA Stock in 2026?
Data-driven analysis and honest assessment for DaVita HealthCare Partners Inc
Current Price: $110.10P/E: 11.5
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Attractive P/E of 11.5
Declining -0%
Thin margins (0% net)
Financial health data limited
Excellent FCF yield of 23.4%
Balanced insider activity
Key Investment Metrics
Current Price
$110.10
P/E Ratio
11.50
Revenue Growth
0.0%
Profit Margin
0.1%
Market Cap
$8.0B
Dividend Yield
None
How DVA Compares to Competitors
Understanding how DVA stacks up against peers helps inform your investment decision.
How DVA Compares to Peers
Upcoming Events for DVA
+5 Reasons TO Buy DVA
1. High free cash flow yield of 23.4%
strongFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
2. Attractively valued at 11.5x earnings
moderateA P/E ratio of 11.5 is below the market average of ~20x, suggesting the stock may be undervalued.
-5 Reasons NOT to Buy DVA
1. Thin profit margins of 0.1%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy DVA?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
- ✓
Value Investors
P/E of 11.5 offers margin of safety
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in DVA, compare these Healthcare peers:
Pro tip: Compare DVA directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for DVA
Frequently Asked Questions
What is DVA stock price today?
DVA (DaVita HealthCare Partners Inc) stock is trading at $110.10 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is DVA stock going up or down today?
DVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy DVA stock now?
The decision to buy DVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is DVA a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for DVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is DVA stock overvalued or undervalued?
DVA currently trades at a P/E ratio of 11.50, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if DVA is fairly priced.
What is DVA's P/E ratio?
DVA has a price-to-earnings (P/E) ratio of 11.50, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is DVA's market cap?
DVA (DaVita HealthCare Partners Inc) has a market capitalization of $7.97 billion, making it a small-cap stock.
What is DVA's price to book ratio?
DVA trades at a price-to-book (P/B) ratio of 21.63, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about DaVita HealthCare Partners Inc
Full Stock Analysis
Complete DVA overview with charts and data
Is DVA Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how DVA stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to DaVita HealthCare Partners Inc
Complete DVA Analysis
Compare DVA With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.